Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Xtacy Therapeutics ( (TSE:LOAN) ) has issued an announcement.
Pegasus Mercantile Inc. announced that it has missed the filing deadline for its audited annual financial statements for the year ended September 30, 2024, due to a change in directors and audit procedures following an increase in client base and M&A discussions. The company has obtained a Management Cease Trade Order to allow more time for filing, expecting to complete the process by March 31, 2025, while maintaining alternative information guidelines and limiting trading activities for specific executives.
More about Xtacy Therapeutics
Pegasus Mercantile Inc., formerly known as Xtacy Therapeutics Corp., is involved in the financial services sector, with its shares listed on the Canadian Securities Exchange, Frankfurt Stock Exchange, and OTC markets.
YTD Price Performance: 25.00%
Average Trading Volume: 117,535
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.41M
For a thorough assessment of LOAN stock, go to TipRanks’ Stock Analysis page.
